Using Dabigatran in Patients With Stroke A Practical Guide for Clinicians

被引：30
作者：
Alberts, Mark J. [1 ]
Bernstein, Richard A. [1 ]
Naccarelli, Gerald V. [2 ]
Garcia, David A. [3 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[2] Penn State Heart & Vasc Inst, Hershey, PA USA
[3] Univ New Mexico, Sch Med, Albuquerque, NM 87131 USA
来源：
STROKE | 2012年 / 43卷 / 01期
关键词：
antithrombotics; prevention; therapy; thrombosis; DIRECT THROMBIN INHIBITOR; ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN ACTIVATOR; ATRIAL-FIBRILLATION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; HEMORRHAGIC TRANSFORMATION; TASK-FORCE; WARFARIN; RISK; THERAPY;
D O I：
10.1161/STROKEAHA.111.622498
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：271 / 279
页数：9
相关论文
共 50 条
  • [41] Thrombolysis and thrombectomy in patients treated with dabigatran with acute ischemic stroke: Expert opinion
    Diener, H. C.
    Bernstein, R.
    Butcher, K.
    Campbell, B.
    Cloud, G.
    Davalos, A.
    Davis, S.
    Ferro, J. M.
    Grond, M.
    Krieger, D.
    Ntaios, G.
    Slowik, A.
    Touze, E.
    INTERNATIONAL JOURNAL OF STROKE, 2017, 12 (01) : 9 - 12
  • [42] Dabigatran and Factor Xa Inhibitors for Stroke Prevention in Patients with Nonvalvular Atrial Fibrillation
    Uchiyama, Shinichiro
    Ibayashi, Setsuro
    Matsumoto, Masayasu
    Nagao, Takehiko
    Nagata, Ken
    Nakagawara, Jyoji
    Tanahashi, Nori
    Tanaka, Kortaro
    Toyoda, Kazunori
    Yasaka, Masahiro
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2012, 21 (03) : 165 - 173
  • [43] Incidence and Management of Ischemic Stroke and Intracerebral Hemorrhage in Patients on Dabigatran Etexilate Treatment
    Watanabe, Masaki
    Siddiqui, Fazeel M.
    Qureshi, Adnan I.
    NEUROCRITICAL CARE, 2012, 16 (01) : 203 - 209
  • [44] Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention for Newly Diagnosed and Treatment-Naive Atrial Fibrillation Patients: An Update Using 2013-2014 Data
    Brown, Joshua D.
    Shewale, Anand R.
    Talbert, Jeffery C.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2017, 23 (09) : 958 - 967
  • [45] Cost-effectiveness of Dabigatran Compared With Rivaroxaban for Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation in China
    Dong, Shu-Jie
    Wu, Bin
    Zhai, Suo-Di
    Zhang, Yan-Jun
    Chu, Yun-Bo
    Gupta, Parul
    Li, Ya-Huei
    CLINICAL THERAPEUTICS, 2020, 42 (01) : 144 - 156
  • [46] Intracranial Hemorrhage During Dabigatran Treatment - Case Series of Eight Patients
    Komori, Motohiro
    Yasaka, Masahiro
    Kokuba, Kazuhito
    Matsuoka, Hideki
    Fujimoto, Shigeru
    Yoshida, Megumu
    Kameda, Katsuharu
    Shono, Tadahisa
    Nagata, Shinji
    Ago, Tetsuro
    Kitazono, Takanari
    Okada, Yasushi
    CIRCULATION JOURNAL, 2014, 78 (06) : 1335 - 1341
  • [47] Dabigatran for Stroke Prevention in All Patients with Atrial Fibrillation?
    Hunchuck, Jonathan E.
    Lake, Jennifer D.
    PHARMACOTHERAPY, 2011, 31 (08): : 725 - 728
  • [48] ACUTE STROKE: BASIC CONCEPTS AND USE OF IMAGING FOR CLINICIANS
    Castillo, M.
    Alvarez, H.
    JBR-BTR, 2013, 96 (01): : 3 - 9
  • [49] Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source
    Diener, H. -C.
    Sacco, R. L.
    Easton, J. D.
    Granger, C. B.
    Bernstein, R. A.
    Uchiyama, S.
    Kreuzer, J.
    Cronin, L.
    Cotton, D.
    Grauer, C.
    Brueckmann, M.
    Chernyatina, M.
    Donnan, G.
    Ferro, J. M.
    Grand, M.
    Kallmuenzer, B.
    Krupinski, J.
    Lee, B. -C.
    Lemmens, R.
    Masjuan, J.
    Odinak, M.
    Saver, J. L.
    Schellinger, P. D.
    Toni, D.
    Toyoda, K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (20) : 1906 - 1917
  • [50] Analyzing and predicting the risk of death in stroke patients using machine learning
    Zhu, Enzhao
    Chen, Zhihao
    Ai, Pu
    Wang, Jiayi
    Zhu, Min
    Xu, Ziqin
    Liu, Jun
    Ai, Zisheng
    FRONTIERS IN NEUROLOGY, 2023, 14
12345